Tag: CBT > Federal Cannabis Research

Industry Headlines

MMJ to File Emergency Injunction Against DEA’s ‘Unconstitutional Marijuana Hearing’

MMJ BioPharma Cultivation, a company seeking DEA registration to cultivate cannabis for research, is hoping to avoid an administrative hearing.

May 1, 2025

Federal Cannabis Legalization

US House Members Introduce Bipartisan Bill to Lay Groundwork for Federal Cannabis Legalization

GOP Rep. Dave Joyce and Democratic Leader Hakeem Jeffries teamed up on the PREPARE Act to create a regulatory structure for cannabis.

April 21, 2025

Cannabis Industry Research

The Man Behind DEA’s Federal Marijuana Scam

DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.

January 28, 2025

Industry Headlines

Does Medical Cannabis Have Physical, Mental Health Risks? Rutgers Health Kicks Off Study

Rutgers Health researchers will emphasize cannabis use disorder, which involves tolerance and dependence, in the five-year, federally funded study.

December 17, 2024

Industry Headlines

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.

December 11, 2024

Industry Headlines

FDA Clears MAPS Researchers to Proceed With Cannabis Study for Veterans With PTSD

The Multidisciplinary Association for Psychedelic Studies (MAPS) researchers negotiated with the FDA for three years.

November 22, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Hemp Regulations in U.S.

US Government Selling Reference Material to Hemp, Cannabis Testing Labs to Ensure Accuracy

The National Institute of Standards and Technology is charging $783 for three 1.5-gram hemp samples to help labs calibrate their methods for accurate labeling.

July 9, 2024

Advocacy for Cannabis Legalization

Senate Democrats Introduce Bill to Federally Legalize Cannabis

The Cannabis Administration and Opportunity Act aims to deschedule marijuana by removing it from the Controlled Substances Act.

May 1, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024

Cannabis Rescheduling

Biden’s Failed Actions on Cannabis Issues ‘Borders on Political Malpractice,’ Lawmaker Says

Rep. Earl Blumenauer asked Health Secretary Xavier Becerra to relay his concerns on cannabis reform to the president during a committee hearing.

March 22, 2024